{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Neurobiology of Co-Morbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence

Purpose of Activity

To provide information from a literature review on the current state of evidence on the neurobiology of dual disorders.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Examine the incidence of substance use and co-morbid psychiatric disorders as well as related neuropathology, functional neuroimaging, and genetics.
  2. Identify biomarkers and neuroendocrinology related to co-morbid substance use and psychiatric disorders.
Price: $17.95


  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Test Code: JAN0117
Published: Jan/Mar 2017
Expires: 3/5/2021
Passing Score: 13/18 (72%)
Authors: Yatan Pal Singh Balhara, MD, DNB (Psychiatry), MNAMS; Pooja Patnaik Kuppili, MD (Psychiatry); Rishab Gupta, MD (Psychiatry)